Literature DB >> 2567551

Immunohistochemical localization of the alpha and beta subunits of S-100 protein in pleomorphic adenoma of the salivary glands.

T Ninomiya1, R Naito, Y Okada, K Kobayashi, M Mori, K Tsukitani.   

Abstract

The immunohistochemical expression of the alpha and beta subunits of S-100 protein in reactive, modified and transformed of myoepithelial cells, salivary pleomorphic was investigated using monoclonal antibodies. With S-100 alpha, normal salivary glands showed strong staining in serous acinar cells and moderate to slight staining in ductal segments, and with S-100 beta staining was slight or negative in acinar cells, but strong in nerve fibres. In pleomorphic salivary adenomas, the immunohistochemical distribution of S-100 alpha and beta proteins indicated great variation in the tumour cells. Some neoplastic cells gave similar staining for both S-100 alpha and beta, others were strongly positive for S-100 alpha and stained only slightly for S-100 beta, or vice versa. Yet other cells were positive for S-100 alpha and negative for S-100 beta, or vice versa. Pleomorphic salivary adenomas were classified both by histopathological criteria and by their staining pattern for S-100 alpha and beta proteins. Great heterogeneity in S-100 alpha and beta protein expression was found in individual tumour cells of both ductal and myoepithelial origin, and no regular pattern was identified. The cellular origin of salivary pleomorphic adenomas is discussed in terms of S-100 alpha and beta protein immunohistochemistry. Pleomorphic adenoma cells may be transformed from reserve cells into tumour cells displaying biologic properties of myoepithelial cells, ductal cells, or a mixture of both.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567551     DOI: 10.1007/BF02899066

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  7 in total

1.  S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors.

Authors:  I Dardick; M Stratis; W R Parks; F G DeNardi; H J Kahn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

2.  Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in brain tumors.

Authors:  K Hayashi; Y Hoshida; Y Horie; K Takahashi; K Taguchi; H Sonobe; Y Ohtsuki; T Akagi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  An immunohistochemical study of bone morphogenetic protein in pleomorphic adenoma of the salivary gland.

Authors:  Y Lianjia; J Yan; N Hitoshi; S Shinichiro; K Akihide; M Masahiko
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Expression of S-100 protein and glial fibrillary acidic protein in cultured submandibular gland epithelial cells and salivary gland tissues. Histogenetic implication for salivary gland tumors.

Authors:  M Okura; T Hiranuma; G Tominaga; H Yoshioka; T Aikawa; K Shirasuna; T Matsuya
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

5.  Plasmacytoid cells in salivary-gland pleomorphic adenomas: evidence of luminal cell differentiation.

Authors:  Yuzo Ogawa; Mitsunobu Kishino; Yukako Atsumi; Masaya Kimoto; Yasuo Fukuda; Takeshi Ishida; Naokuni Ijuhin
Journal:  Virchows Arch       Date:  2003-08-28       Impact factor: 4.064

6.  Histogenesis and possible mechanism of chondroid changes in mixed tumour of the skin: immunohistochemical evaluation of bone morphogenetic protein, glycosaminoglycans, keratin, vimentin and neuronal markers.

Authors:  M Mori; P Shrestha; F Sakamoto; L J Yang; C Qin; T Tsujimura
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Phenotype and cell proliferation activity of duct-like structures in human sublingual glands: a histological and immunohistochemical study.

Authors:  Elen de Souza Tolentino; Cleverson Soares Teixeira; Luciana Reis Azevedo-Alanis; Heitor Marques Honório; José Humberto Damante
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.